Research map: Clinical and Functional Impact of CHMP3 in Pancreatic Ductal Adenocarcinoma

Back to the article

Papers in this map

  1. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies · Erik B von Elm · 2008 · 17695 citations · Cited by this paper
  2. ASO Author Reflections: Preserving the Liver, Not Just Minimizing the Incision · Maria Christodoulou · 2026 · Related
  3. Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas · Reuben M. Moncada · 2020 · 1121 citations · Cited by this paper
  4. ICG-only Sentinel Lymph Node Biopsy in Breast Cancer: A Prospective UK Cohort Demonstrating Consistent Detection Across Patient and Tumour Characteristics—A Follow-on to the INFLUENCE Trial · 2026 · Related
  5. ESCRT-III Acts Downstream of MLKL to Regulate Necroptotic Cell Death and Its Consequences · Yi‐Nan Gong · 2017 · 712 citations · Cited by this paper
  6. ASO Visual Abstract: Resection of Primary Lung Tumors in Patients with Stage IV EGFR-Mutant Lung Adenocarcinoma before Progression under First-Line TKI Treatment and Its Impact on Prognosis · 2026 · Related
  7. Reverse-topology membrane scission by the ESCRT proteins · Johannes Schöneberg · 2016 · 462 citations · Cited by this paper
  8. ASO Visual Abstract: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy in the I-SPY2 Trial · 2026 · Related
  9. The ESCRT machinery · Oliver Ioannis Schmidt · 2012 · 458 citations · Cited by this paper
  10. ASO Visual Abstract: Risk of pN2/3 Understaging in Sentinel Node-Positive ER+/HER2− Breast Cancer: A Composite Clinicopathologic Score for Safe RxPONDER and MonarchE Application · 2026 · Related
  11. The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives · Shun Wang · 2021 · 383 citations · Cited by this paper
  12. ASO Practice Guidelines Series: Resectable Colorectal Cancer · 2026 · Related
  13. ESCRT-III-mediated membrane repair in cell death and tumor resistance · Jiao Liu · 2020 · 107 citations · Cited by this paper
  14. Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy on the I-SPY2 Trial · 2026 · Related
  15. Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer · Dimitrios Stefanoudakis · 2024 · 104 citations · Cited by this paper
  16. Who is at Risk of Residual Tumor and Pathologic Upstaging at a Second TURBT in Non–Muscle-Invasive Bladder Cancer? · 2026 · Related
  17. miR‐122‐5p promotes aggression and epithelial‐mesenchymal transition in triple‐negative breast cancer by suppressing charged multivesicular body protein 3 through mitogen‐activated protein kinase signaling · Zheng Wang · 2019 · 70 citations · Cited by this paper
  18. ASO Visual Abstract: Timing of Surgical Axillary Staging and Impact on Technical Success of Immediate Lymphatic Reconstruction Following Axillary Lymph Node Dissection · 2026 · Related
  19. Incidence, mortality, survival, and treatment statistics of cancers in digestive organs—Japanese cancer statistics 2024 · Takahiro Higashi · 2024 · 53 citations · Cited by this paper
  20. ASO Visual Abstract: Prognostic Relevance of Surgical Margins According to KRAS and BRAF Status in Colorectal Liver Metastases—BRAF-KRAS LiverMet Collaborative Group · 2026 · Related
  21. Chromatin modified protein 4C (CHMP4C) facilitates the malignant development of cervical cancer cells · Shu‐Li Lin · 2020 · 45 citations · Cited by this paper
  22. Chmp 1A is a mediator of the anti-proliferative effects of All-trans Retinoic Acid in human pancreatic cancer cells · Jing Li · 2009 · 33 citations · Cited by this paper
  23. Advances in immunotherapy for pancreatic ductal adenocarcinoma · Motoki Miyazawa · 2021 · 31 citations · Cited by this paper
  24. Unveiling the resistance to therapies in pancreatic ductal adenocarcinoma · Ashu Shah · 2024 · 31 citations · Cited by this paper
  25. CHMP4C promotes pancreatic cancer progression by inhibiting necroptosis via the RIPK1/RIPK3/MLKL pathway · Longchen Yu · 2025 · 24 citations · Cited by this paper
  26. CHMP3 promotes the progression of hepatocellular carcinoma by inhibiting caspase‑1‑dependent pyroptosis · Yuting Zheng · 2023 · 19 citations · Cited by this paper
  27. CHMP4C as a novel marker regulates prostate cancer progression through cycle pathways and contributes to immunotherapy · Hongtuan Zhang · 2023 · 14 citations · Cited by this paper
  28. Current status and future perspectives of clinical research in pancreatic cancer: Establishment of evidence by science · Ning Pu · 2021 · 11 citations · Cited by this paper
  29. Immunohistochemical Evaluation of the Expression of Specific Membrane Antigens in Patients with Pancreatic Ductal Adenocarcinoma · Alberto Nicoletti · 2023 · 10 citations · Cited by this paper
  30. Development and verification of a prognostic model for colon cancer on pyroptosis-related genes · Zizhen Wu · 2022 · 6 citations · Cited by this paper
  31. ARID4B Promotes the Progression of Hepatocellular Carcinoma Through the PI3K/AKT Pathway · Munetoshi Akaoka · 2025 · 6 citations · Cited by this paper
  32. ESCRT may function as a tumor biomarker, transitioning from pan-cancer analysis to validation within breast cancer · Xiaorui Chen · 2025 · 5 citations · Cited by this paper

Source: OpenAlex (CC0)